Cargando…
Refining the definition of clinically important mineral and bone disorder in hemodialysis patients
BACKGROUND: It is important to identify an easily defined subset of patients at increased risk of adverse clinical outcomes associated with mineral and bone disorder (MBD) biomarkers (parathyroid hormone, calcium and phosphate). METHODS: Observational cohort study of 26 221 prevalent hemodialysis pa...
Autores principales: | Danese, Mark D., Halperin, Marc, Lowe, Kimberly A., Bradbury, Brian D., Do, Thy P., Block, Geoffrey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513894/ https://www.ncbi.nlm.nih.gov/pubmed/25817224 http://dx.doi.org/10.1093/ndt/gfv034 |
Ejemplares similares
-
Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis
por: Block, Geoffrey A., et al.
Publicado: (2016) -
Mineral and Bone Disease in Hemodialysis Patients
por: Theofilou, Paraskevi
Publicado: (2013) -
Dynamics of cinacalcet use and biochemical control in hemodialysis patients: a retrospective New-user cohort design
por: Reams, B. Diane, et al.
Publicado: (2015) -
Parathyroid hormone change after cinacalcet initiation and one-year clinical outcome risk: a retrospective cohort study
por: St. Peter, Wendy L, et al.
Publicado: (2015) -
Impact of Hemodialysis Catheter Dysfunction on Dialysis and Other Medical Services: An Observational Cohort Study
por: Griffiths, Robert I., et al.
Publicado: (2012)